GUSTO 1y follow-up (TCZ +IVMPx3 but no ongoing PNL in new GCA): initial 24w results disappointing (permanent visual loss x1) BUT follow-up at 2y: control overwhelmingly maintained in responders We need to keep asking: can we use less PNL in GCA? When? ABST0470 #ACR22 @RheumNow https://t.co/smyw2nykO5 https://t.co/d2at0pJlSB